Cor Vasa 2013, 55(4):e293-e300 | DOI: 10.1016/j.crvasa.2013.07.002

Optimization of cardiac resynchronization therapy in non-responders

Milan Sepšia,*, Lubomír Křivana, Milan Kozáka, Marek Šeboa, Martin Poloczeka, Jiří Jarkovskýb, Lukáš Rybkaa, Lenka Kubkováa, Jitka Vlašínováa, Jindřich Špinara
a Interní kardiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice Brno, Brno, Česká republika
b Institut biostatistiky a analýz Lékařské a Přírodovědecké fakulty Masarykovy univerzity, Brno, Česká republika

Background: Cardiac resynchronization therapy plays important role in treatment of heart failure patients with low left ventricular ejection fraction. However, a significant number of patients do not improve after implantation. Optimization of atrioventricular and interventricular delay could improve clinical status of these patients.

Objectives: The purpose of this study was to compare optimization of atrioventricular (AV) and interventricular (VV) delays with aortic velocity-time integral (VTI) and with maximal value of the first derivative of a left ventricular pressure signal (LVdP/dtmax).

Methods: Fifteen non-responders were optimized with aortic VTI method and QuickOpt. After 3 months the follow up echocardiography and clinical evaluation were done. Ten non-responders were optimized with LVdP/dtmax and QuickOpt. After 3 month follow up echocardiography and clinical evaluation were done.

Results: In the first group of patients (age 74.3 years [65.3, 84.3], 83.4% male, etiology: 66% ischemic heart disease, NYHA class before optimization III 66.7%, III-IV 33.3%, LVEF 23.0% [15.0; 32.0]), no correlation between AV and VV delays setting obtained from aortic VTI and QuickOpt was found. Optimization generated shorter QRS complex. After 3 months of follow up, there was no change in echo parameters or NYHA class. In the second group of patients (age 76.7 years [66.6, 82.4], 90% male, etiology: 60% ischemic heart disease, NYHA class before optimization III 50%, III-IV 50%, LVEF 29.5% [10.0; 35.0]), no correlation between AV and VV delays setting obtained from LVdP/dtmax and QuickOpt was found. Optimization in this group of patients also generated shorter QRS complex. After 3 months, increase in LVEF was observed, but other echo parameters and NYHA class remained unchanged.

Conclusion: Using aortic VTI guided optimization in CRT devices did not bring any profit for non-responder patients. Echocardiography parameters and NYHA status did not change in 3 month follow up. Using invasive LVdP/dtmax leads to a change in left ventricular ejection fraction, but NYHA class remains unchanged.

Keywords: Cardiac resynchronization therapy; Chronic heart failure; Echocardiography; Hemodynamics; Optimization

Received: January 3, 2013; Revised: July 2, 2013; Accepted: July 3, 2013; Published: August 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sepši M, Křivan L, Kozák M, Šebo M, Poloczek M, Jarkovský J, et al.. Optimization of cardiac resynchronization therapy in non-responders. Cor Vasa. 2013;55(4):e293-300. doi: 10.1016/j.crvasa.2013.07.002.
Download citation

References

  1. C. Linde, W.T. Abraham, M.R. Gold, et al., Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms, Journal of the American College of Cardiology 52 (23) (2008) 1834-1843. Go to original source... Go to PubMed...
  2. W.T. Abraham, J.B. Young, A.R. León, et al., Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure, Circulation 110 (18) (2004) 2864-2868. Go to original source... Go to PubMed...
  3. J.C. Daubert, L. Saxon, P.B. Adamson, et al., 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management, Heart Rhythm 9 (9) (2012) 1524-1576. Go to original source... Go to PubMed...
  4. L. Zanolla, P. Zardini, Selection of endpoints for heart failure clinical trials, European Journal of Heart Failure 5 (6) (2003) 717-723. Go to original source... Go to PubMed...
  5. J.C. Hsu, S.D. Solomon, M. Bourgoun, et al., Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) study, Journal of the American College of Cardiology 59 (25) (2012) 2366-2373. Go to original source... Go to PubMed...
  6. K.A. Ellenbogen, M.R. Gold, T.E. Meyer, et al., Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy, Circulation 122 (25) (2010) 2660-2668. Go to original source... Go to PubMed...
  7. J.H. Baker II, J. Kenzie III, S. Beau, et al., Acute evaluation of programmer-guided AV/PV and VV delay optimization comparing an IEGM method and echocardiogram for cardiac resynchronization therapy in heart failure patients and dual-chamber ICD implants, Journal of Cardiovascular Electrophysiology 18 (2) (2007) 185-191. Go to original source... Go to PubMed...
  8. M.A. Quiñones, C.M. Otto, M. Stoddard, et al., Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography, Journal of the American Society of Echocardiography 15 (2) (2002) 167-184. Go to original source... Go to PubMed...
  9. D. Mehta, S. Gilmour, D.E. Wardet, et al., Optimal atrioventricular delay at rest and during exercise in patients with dual chamber pacemakers: a non-invasive assessment by continuous wave Doppler, British Heart Journal 61 (2) (1989) 161-166. Go to original source... Go to PubMed...
  10. N.S. Sawhney, A.D. Waggoner, S. Garhwal, et al., Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy, Heart Rhythm 1 (5) (2004) 562-567. Go to original source... Go to PubMed...
  11. D.A. Kass, W.L. Maughan, Z.M. Guo, et al., Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships, Circulation 76 (6) (1987) 1422-1436. Go to original source... Go to PubMed...
  12. A. Auricchio, C. Stellbrink, M. Block, et al., Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure, Circulation 99 (23) (1999) 2993-3001. Go to original source... Go to PubMed...
  13. B.M. van Gelder, F.A. Bracke, A. Meijer, et al., Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy, American Journal of Cardiology 93 (12) (2004) 1500-1503. Go to original source... Go to PubMed...
  14. W.T. Abraham, D. Gras, C.M. Yu, et al., Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial, American Heart Journal 159 (6) (2010) 944-948. Go to original source... Go to PubMed...
  15. B. K. Fornwalt, W.W. Sprague, P. BeDell, et al., Agreement is poor among current criteria used to define response to cardiac resynchronization therapy, Circulation 121 (2010) 1985-1991. Go to original source... Go to PubMed...
  16. H. Burri, H. Sunthorn, P. Dorsaz, et al., Thresholds and complications with right ventricular septal pacing compared to apical pacing, Pacing and Clinical Electrophysiology 30 (Suppl. S1) (2007) S75-S78. Go to original source... Go to PubMed...
  17. J.E. Kerlan, N.S. Sawhney, A.D. Waggoner, et al., Prospective comparison of echocardiographic atrioventricular delay optimization methods for cardiac resynchronization therapy, Heart Rhythm 3 (2) (2006) 148-154. Go to original source... Go to PubMed...
  18. S.E. Hardt, S.H. Yazdi, A. Bauer, et al., Immediate and chronic effects of AV-delay optimization in patients with cardiac resynchronization therapy, International Journal of Cardiology 115 (3) (2007) 318-325. Go to original source... Go to PubMed...
  19. G. Boriani, C.P. Müller, K.H. Seidl, et al., Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study, American Heart Journal 151 (5) (2006) 1057-1065. Go to original source... Go to PubMed...
  20. R.K. Rao, U.N. Kumar, J. Schafer, et al., Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: a randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing, Circulation 115 (16) (2007) 2136-2144. Go to original source... Go to PubMed...
  21. B.M. van Gelder, A. Meijer, F.A. Bracke, The optimized V-V interval determined by interventricular conduction times versus invasive measurement by LVdP/dtMAX, Journal of Cardiovascular Electrophysiology 19 (9) (2008) 939-944. Go to original source... Go to PubMed...
  22. W.T. Abraham, et al., Results from the FREEDOM Trial-assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy. SP08. Late-Breaking Clinical Trials, HRS 2010, Denver, Colorado, 2010.




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.